139 reports of this reaction
6.8% of all CARBOPROST TROMETHAMINE reports
#3 most reported adverse reaction
OFF LABEL USE is the #3 most commonly reported adverse reaction for CARBOPROST TROMETHAMINE, manufactured by Pharmacia & Upjohn Company LLC. There are 139 FDA adverse event reports linking CARBOPROST TROMETHAMINE to OFF LABEL USE. This represents approximately 6.8% of all 2,057 adverse event reports for this drug.
Patients taking CARBOPROST TROMETHAMINE who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OFF LABEL USE is moderately reported among CARBOPROST TROMETHAMINE users, representing a notable but not dominant share of adverse events.
In addition to off label use, the following adverse reactions have been reported for CARBOPROST TROMETHAMINE:
The following drugs have also been linked to off label use in FDA adverse event reports:
OFF LABEL USE has been reported as an adverse event in 139 FDA reports for CARBOPROST TROMETHAMINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
OFF LABEL USE accounts for approximately 6.8% of all adverse event reports for CARBOPROST TROMETHAMINE, making it one of the most commonly reported side effect.
If you experience off label use while taking CARBOPROST TROMETHAMINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.